ADOCIA SAS (ADOC.PA) Fundamental Analysis & Valuation
EPA:ADOC • FR0011184241
Current stock price
4.648 EUR
+0.34 (+7.89%)
Last:
This ADOC.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ADOC.PA Profitability Analysis
1.1 Basic Checks
- In the past year ADOC has reported negative net income.
- ADOC had a negative operating cash flow in the past year.
- ADOC had negative earnings in each of the past 5 years.
- In the past 5 years ADOC always reported negative operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of -35.67%, ADOC is in line with its industry, outperforming 41.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -35.67% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-47.28%
ROA(5y)-53.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Gross Margin of ADOC (79.22%) is better than 69.05% of its industry peers.
- ADOC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 79.22% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. ADOC.PA Health Analysis
2.1 Basic Checks
- ADOC does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, ADOC has more shares outstanding
- The number of shares outstanding for ADOC has been increased compared to 5 years ago.
- ADOC has a better debt/assets ratio than last year.
2.2 Solvency
- ADOC has an Altman-Z score of -0.85. This is a bad value and indicates that ADOC is not financially healthy and even has some risk of bankruptcy.
- ADOC has a worse Altman-Z score (-0.85) than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.85 |
ROIC/WACCN/A
WACC7.48%
2.3 Liquidity
- A Current Ratio of 1.14 indicates that ADOC should not have too much problems paying its short term obligations.
- ADOC has a worse Current ratio (1.14) than 71.43% of its industry peers.
- A Quick Ratio of 1.12 indicates that ADOC should not have too much problems paying its short term obligations.
- ADOC has a worse Quick ratio (1.12) than 69.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 1.12 |
3. ADOC.PA Growth Analysis
3.1 Past
- ADOC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.52%, which is quite impressive.
- Looking at the last year, ADOC shows a very strong growth in Revenue. The Revenue has grown by 1879.16%.
- Measured over the past years, ADOC shows a very strong growth in Revenue. The Revenue has been growing by 34.18% on average per year.
EPS 1Y (TTM)63.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.8%
Revenue 1Y (TTM)1879.16%
Revenue growth 3Y86.19%
Revenue growth 5Y34.18%
Sales Q2Q%N/A
3.2 Future
- Based on estimates for the next years, ADOC will show a very negative growth in Earnings Per Share. The EPS will decrease by -36.82% on average per year.
- The Revenue is expected to decrease by -18.09% on average over the next years. This is quite bad
EPS Next Y-84.23%
EPS Next 2Y-82.4%
EPS Next 3Y-28.13%
EPS Next 5Y-36.82%
Revenue Next Year-66.58%
Revenue Next 2Y-25.22%
Revenue Next 3Y-48.43%
Revenue Next 5Y-18.09%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. ADOC.PA Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for ADOC. In the last year negative earnings were reported.
- Based on the Price/Forward Earnings ratio of 24.86, the valuation of ADOC can be described as rather expensive.
- Based on the Price/Forward Earnings ratio, ADOC is valued a bit cheaper than the industry average as 76.19% of the companies are valued more expensively.
- When comparing the Price/Forward Earnings ratio of ADOC to the average of the S&P500 Index (37.96), we can say ADOC is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 24.86 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- ADOC's earnings are expected to decrease with -28.13% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-82.4%
EPS Next 3Y-28.13%
5. ADOC.PA Dividend Analysis
5.1 Amount
- No dividends for ADOC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ADOC.PA Fundamentals: All Metrics, Ratios and Statistics
EPA:ADOC (4/14/2026, 5:29:56 PM)
4.648
+0.34 (+7.89%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-24 2026-02-24/amc
Earnings (Next)05-12 2026-05-12
Inst Owners12.04%
Inst Owner ChangeN/A
Ins Owners3.53%
Ins Owner ChangeN/A
Market Cap91.15M
Revenue(TTM)10.35M
Net Income(TTM)-9.72M
Analysts84.44
Price Target15.5 (233.48%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)84.21%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-30.74%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 24.86 | ||
| P/S | 8.81 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.56
EYN/A
EPS(NY)0.19
Fwd EY4.02%
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.78
OCFYN/A
SpS0.53
BVpS-0.03
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -35.67% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 79.22% | ||
| FCFM | N/A |
ROA(3y)-47.28%
ROA(5y)-53.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 40.43% | ||
| Cap/Sales | 2.53% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | -0.85 |
F-Score4
WACC7.48%
ROIC/WACCN/A
Cap/Depr(3y)32.19%
Cap/Depr(5y)28.97%
Cap/Sales(3y)3.68%
Cap/Sales(5y)12.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.8%
EPS Next Y-84.23%
EPS Next 2Y-82.4%
EPS Next 3Y-28.13%
EPS Next 5Y-36.82%
Revenue 1Y (TTM)1879.16%
Revenue growth 3Y86.19%
Revenue growth 5Y34.18%
Sales Q2Q%N/A
Revenue Next Year-66.58%
Revenue Next 2Y-25.22%
Revenue Next 3Y-48.43%
Revenue Next 5Y-18.09%
EBIT growth 1Y47.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-75.21%
EBIT Next 3Y-29.09%
EBIT Next 5YN/A
FCF growth 1Y-33.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.93%
OCF growth 3YN/A
OCF growth 5YN/A
ADOCIA SAS / ADOC.PA Fundamental Analysis FAQ
What is the fundamental rating for ADOC stock?
ChartMill assigns a fundamental rating of 2 / 10 to ADOC.PA.
What is the valuation status for ADOC stock?
ChartMill assigns a valuation rating of 1 / 10 to ADOCIA SAS (ADOC.PA). This can be considered as Overvalued.
What is the profitability of ADOC stock?
ADOCIA SAS (ADOC.PA) has a profitability rating of 1 / 10.
Can you provide the financial health for ADOC stock?
The financial health rating of ADOCIA SAS (ADOC.PA) is 1 / 10.
What is the earnings growth outlook for ADOCIA SAS?
The Earnings per Share (EPS) of ADOCIA SAS (ADOC.PA) is expected to decline by -84.23% in the next year.